Carregant...
n-3 PUFAs reduce tumor load and improve survival in a NASH-tumor mouse model
BACKGROUND: With 9.1% of all cancer deaths, hepatocellular carcinoma is the second leading cause of cancer deaths worldwide. Due to the increasing prevalence of metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has evolved into a major risk factor for hepatocellular carcinoma development....
Guardat en:
| Publicat a: | Ther Adv Chronic Dis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728677/ https://ncbi.nlm.nih.gov/pubmed/31523414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319872118 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|